IL144645A0 - Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid - Google Patents
Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acidInfo
- Publication number
- IL144645A0 IL144645A0 IL14464500A IL14464500A IL144645A0 IL 144645 A0 IL144645 A0 IL 144645A0 IL 14464500 A IL14464500 A IL 14464500A IL 14464500 A IL14464500 A IL 14464500A IL 144645 A0 IL144645 A0 IL 144645A0
- Authority
- IL
- Israel
- Prior art keywords
- fatty acid
- nutritional supplement
- carbon fatty
- triglycerides
- pharmaceutical preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11903899P | 1999-02-05 | 1999-02-05 | |
PCT/US2000/003022 WO2000045649A1 (en) | 1999-02-05 | 2000-02-03 | Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid |
Publications (1)
Publication Number | Publication Date |
---|---|
IL144645A0 true IL144645A0 (en) | 2002-05-23 |
Family
ID=22382253
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14464500A IL144645A0 (en) | 1999-02-05 | 2000-02-03 | Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1150579B1 (ja) |
JP (2) | JP4902906B2 (ja) |
KR (1) | KR100702823B1 (ja) |
CN (2) | CN101574335A (ja) |
AT (1) | ATE303079T1 (ja) |
AU (1) | AU775708C (ja) |
CA (1) | CA2361070C (ja) |
DE (1) | DE60022312T2 (ja) |
HK (1) | HK1042412B (ja) |
HU (1) | HUP0200511A3 (ja) |
IL (1) | IL144645A0 (ja) |
MX (1) | MXPA01007988A (ja) |
NZ (1) | NZ513329A (ja) |
WO (1) | WO2000045649A1 (ja) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003160486A (ja) * | 2001-09-17 | 2003-06-03 | Lion Corp | 経口養育毛剤及び該養育毛剤を含有する飲食品 |
WO2004022051A1 (ja) * | 2002-09-05 | 2004-03-18 | The Nisshin Oillio Group, Ltd. | ペルオキシソーム増殖薬活性化受容体調整剤 |
AU2003261926A1 (en) * | 2002-09-05 | 2004-03-29 | The Nisshin Oillio Group, Ltd. | Slimming agents and foods and drinks comprising the same |
AU2003261928A1 (en) * | 2002-09-05 | 2004-03-29 | The Nisshin Oillio Group, Ltd. | Agents, foods and drinks controlling lipid metabolism |
CA2784585A1 (en) | 2004-07-02 | 2006-02-09 | Baylor Research Institute | Glycogen or polysaccharide storage disease treatment method |
EP1929995A1 (en) * | 2006-12-04 | 2008-06-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Anaplerotic therapy of Huntington disease and other polyglutamine diseases |
DE102008057867A1 (de) * | 2008-11-18 | 2010-05-20 | B. Braun Melsungen Ag | Fettemulsion zur künstlichen Ernährung von schwerkranken Intensivpatienten |
WO2011159634A1 (en) * | 2010-06-14 | 2011-12-22 | Baylor Research Institute | Triheptanoin diet for adult polyglucosan body disease (apbd) treatment |
GB201210699D0 (en) * | 2012-06-15 | 2012-08-01 | Vitaflo Ltd | Nutritional food |
CN104955450A (zh) | 2012-12-13 | 2015-09-30 | 达拉斯贝勒研究院 | 用于治疗葡萄糖转运体1缺乏症的三庚酸甘油酯 |
WO2015073803A1 (en) | 2013-11-14 | 2015-05-21 | The University Of Queensland | Neurodegenerative disorders and methods of treatment and diagnosis thereof |
MY177028A (en) * | 2013-11-14 | 2020-09-02 | Ultragenyx Pharmaceutical Inc | Solid compositions of triglycerides and uses thereof |
EP3370714A4 (en) * | 2015-11-06 | 2019-07-03 | The Children's Hospital of Philadelphia | COMPOSITIONS AND METHODS FOR TREATING FATTY ACID METABOLISM DISORDERS |
US11844775B2 (en) | 2018-07-11 | 2023-12-19 | University of Pittsburgh—of the Commonwealth System of Higher Education | Method of treating fatty acid oxidation disorders using Omega3/Omega6 unsaturated or branched chain fatty acids |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5215834A (en) * | 1975-07-12 | 1977-02-05 | Ajinomoto Kk | Method of producing food composition |
CA1302280C (en) * | 1986-04-21 | 1992-06-02 | Jon Joseph Kabara | Topical antimicrobial pharmaceutical compositions and methods |
US5153221A (en) * | 1990-10-05 | 1992-10-06 | Elena Avram | Method for the treatment of acquired immune deficiency syndrome |
US5569675A (en) * | 1994-03-07 | 1996-10-29 | Bar Ilan University | Methods of using carboxylic acid esters to increase fetal-hemoglobin levels |
DE4439947A1 (de) * | 1994-11-09 | 1996-05-15 | Boehringer Mannheim Gmbh | 2,2-Dichloralkancarbonsäuren, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
CA2263978A1 (en) * | 1996-08-27 | 1998-03-05 | Hemosol Inc. | Enhanced stimulation of erythropoiesis |
US5908631A (en) * | 1997-02-27 | 1999-06-01 | L'oreal S.A. | Monohydric alcohol-free composition for topical use comprising solubilized ethylcellulose |
-
2000
- 2000-02-03 JP JP2000596781A patent/JP4902906B2/ja not_active Expired - Lifetime
- 2000-02-03 AU AU32236/00A patent/AU775708C/en not_active Expired
- 2000-02-03 NZ NZ513329A patent/NZ513329A/en not_active IP Right Cessation
- 2000-02-03 CA CA2361070A patent/CA2361070C/en not_active Expired - Lifetime
- 2000-02-03 MX MXPA01007988A patent/MXPA01007988A/es active IP Right Grant
- 2000-02-03 AT AT00910086T patent/ATE303079T1/de not_active IP Right Cessation
- 2000-02-03 IL IL14464500A patent/IL144645A0/xx not_active IP Right Cessation
- 2000-02-03 DE DE60022312T patent/DE60022312T2/de not_active Expired - Lifetime
- 2000-02-03 EP EP00910086A patent/EP1150579B1/en not_active Expired - Lifetime
- 2000-02-03 WO PCT/US2000/003022 patent/WO2000045649A1/en active IP Right Grant
- 2000-02-03 KR KR1020017009874A patent/KR100702823B1/ko active IP Right Grant
- 2000-02-03 HU HU0200511A patent/HUP0200511A3/hu unknown
- 2000-02-03 CN CNA2008101251285A patent/CN101574335A/zh active Pending
- 2000-02-03 CN CNB008057699A patent/CN100408031C/zh not_active Expired - Lifetime
-
2002
- 2002-03-25 HK HK02102246.6A patent/HK1042412B/zh not_active IP Right Cessation
-
2011
- 2011-11-15 JP JP2011249219A patent/JP5553815B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU775708C (en) | 2005-07-14 |
KR20010108173A (ko) | 2001-12-07 |
JP2002536304A (ja) | 2002-10-29 |
DE60022312T2 (de) | 2006-07-06 |
JP4902906B2 (ja) | 2012-03-21 |
HK1042412B (zh) | 2006-01-06 |
CA2361070A1 (en) | 2000-08-10 |
CN100408031C (zh) | 2008-08-06 |
MXPA01007988A (es) | 2003-07-14 |
HK1042412A1 (en) | 2002-08-16 |
JP2012082202A (ja) | 2012-04-26 |
DE60022312D1 (de) | 2005-10-06 |
HUP0200511A2 (en) | 2002-06-29 |
HUP0200511A3 (en) | 2003-03-28 |
AU775708B2 (en) | 2004-08-12 |
CN1345188A (zh) | 2002-04-17 |
CN101574335A (zh) | 2009-11-11 |
JP5553815B2 (ja) | 2014-07-16 |
EP1150579A1 (en) | 2001-11-07 |
ATE303079T1 (de) | 2005-09-15 |
WO2000045649A1 (en) | 2000-08-10 |
CA2361070C (en) | 2012-04-17 |
NZ513329A (en) | 2003-11-28 |
EP1150579B1 (en) | 2005-08-31 |
KR100702823B1 (ko) | 2007-04-06 |
AU3223600A (en) | 2000-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL144645A0 (en) | Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid | |
CA2382262A1 (en) | A nutritional supplement for lowering serum triglyceride and cholesterol levels | |
EP1174416A4 (en) | ESTERS OF CONJUGATED FATTY ACIDS | |
NZ516101A (en) | Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents | |
HUP9903791A3 (en) | Pure enantiomer basic aryl-cycloalkyl-hydroxycarboxylic acid esters,process for preparing the same and their use in medicaments | |
TR199700537A2 (xx) | Diyete uygun dengelenmi� s�t �r�n�. | |
HK1020316A1 (en) | Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid | |
CA2191645A1 (en) | Pharmaceutical composition comprising l-carnitine or an alkanoyl l-carnitine in combination with a polyunsaturated fatty acid of the omega-3 series for the prevention and the treatment of lipid metabolism disorders | |
ZA200004725B (en) | Process for the fermentative preparation of D-pantothenic acid using coryneform bacteria. | |
HK1043357B (zh) | Lipoxin化合物及其使用 | |
PL1799204T3 (pl) | Kompozycja zawierająca kwasy tłuszczowe omega-3 i omega-6 | |
CA2384859A1 (en) | High lipid diet | |
MY116376A (en) | A food for pregnant and lactating women | |
EP1228708A3 (en) | Milk derived basic protein fraction as agents for improving lipid metabolism and reducing high blood pressure | |
CA2004332A1 (en) | Inhibition of cell adhesion | |
SG162836A1 (en) | Use of a combination comprising l-carnitine or alkanoyl l-carnitine, lipid solubl benzoquinone and omega-3-polyunsaturated fatty acid for the preparation of a dietary supplement or medicament for the treatment of corneal diseases | |
AU5018900A (en) | Lipid metabolism transcription factor | |
CA2386790A1 (en) | Chromium-histidine complexes as nutrient supplements | |
CA2162042A1 (en) | Enteral Nutritional Product | |
CA2335713A1 (en) | Oral dosage form | |
WO2010133377A8 (en) | Fat blends and uses thereof | |
EP1269991A3 (en) | Composition for topical use based on the ethylic ester of linoleic acid and on the triethyl ester of citric acid associated with suitable synergists | |
AU2003249820A1 (en) | Process for increasing the yield of lipid and omega-3 fatty acid in seaweed culture | |
AU6095399A (en) | Food composition based on substance derived from milk comprising conjugate linoleic acid glycerides | |
EP0087863A3 (en) | Pharmaceutical and dietary composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ERR | Corrigendum |
Free format text: JOURNAL NO. 11/2004 P. 3654 PATENT APPLICATION NO. 144645 CORRECT THE NAME OF APPLICANT TO- BAYLOR RESEARCH INSTITUTE |
|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |